UBS lowered the firm’s price target on Northrop Grumman (NOC) to $571 from $583 and keeps a Buy rating on the shares. The ramp to 2025 guidance looks tough, but Northrop Grumman’s record backlog represents a longer term opportunity, the analyst tells investors in a research note.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NOC:
- Northrop Grumman price target lowered to $550 from $600 at Truist
- Northrop Grumman price target lowered to $540 from $557 at Susquehanna
- Northrop Grumman price target lowered to $550 from $585 at BofA
- Northrop Grumman Reports Q1 2025 Financial Results
- Northrop Grumman’s Earnings Call: Achievements and Challenges